Topical NSAIDs Speed Recovery in Acute CSR

 A new study suggests that topical NSAID eye drops can speed up recovery from acute central serous
chorioretinopathy (CSCR), a condition that usually clears on its own in 3–6 months but sometimes causes lasting damage. Researchers compared patients treated with NSAIDs to those simply observed. Those using NSAIDs recovered in weeks instead of months, with COX-2 selective drugs (like bromfenac or nepafenac) working better than ketorolac. All patients regained about 20/20 vision, but early NSAID use may lower risks of long-term complications and reduce the need for costly treatments. The authors recommend considering NSAIDs as a safe, accessible option to shorten disease duration and improve patient quality of life.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH